Medicure (MCUJF) 20-F2020 FY Annual report (foreign)

Filed: 20 Apr 21, 9:25pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absorb, accuracy, addendum, ADP, aimed, alter, Amazon, aneurysmal, angioplasty, aSAH, asymptomatic, attrition, bargaining, biosimilar, capable, carrier, channel, chewed, children, Circulation, computerized, concept, counter, counterfeit, Creek, criterion, CT, cure, decommissioning, dispensing, dosage, dynamic, EBITDA, EMA, EuroPCR, evolution, excellent, EY, facet, foot, forgiven, fourteen, gene, gradient, greatly, hemorrhage, hemorrhagic, Hope, hypercoagulability, hypothetical, hypoxemia, IBR, imaging, improper, incremental, IND, inspired, interface, internationally, inventor, IPA, iSPASM, journal, lessee, likelihood, loading, loyal, loyalty, magnetic, mail, maker, marley, matrix, meaningful, media, merge, methodology, mg, mislabeling, missing, mobile, MRI, nationwide, necessitate, negate, noninferiority, omission, online, Orphan, oxidase, oxygen, pandemic, passed, Paycheck, PCR, physical, picked, pill, Pkwy, placebo, PNPO, popular, popularity, portal, PPP, priority, proof, PRV, PUBLICATON, rapidly, Rare, ratio, refill, remote, renmark, resonance, restoration, RLS, Roadshow, Roman, Salem, SBA, segregation, seller, sensitivity, shop, shutdown, side, slide, societal, Sodium, software, specialist, spending, sponsorship, stimulation, store, strength, stroke, subarachnoid, Subsidy, superior, superiority, symptomatic, tablet, tampering, tomography, trailing, turnover, unavailable, unintentional, Union, USD, Virtual, virtually, voucher, Winston, workload, younger

Removed: accelerated, Acton, AGGRASTAT®and, AGGRASTAT®finished, AGGRASTAT®Injection, AGGRASTAT®may, AGGRASTAT®to, AGGRASTAT®unfinished, aggregated, agreemententered, areacquired, checked, Codification, comprising, Contact, custom, Dap, Dhaduk, economiclife, emerge, emerging, explanatory, Facsimile, Fax, filer, finishedcommercial, formof, GAAP, inCanadian, Indian, influenced, Interactive, lapse, lapsed, line, manufactured, mark, modest, ofActive, ofMedicure, ofPREXXARTAN, ofPREXXARTAN®to, Omgene, participated, payableon, phosphate, PREXXARTAN®and, PREXXARTAN®described, PREXXARTAN®related, recording, release, revise, seasoned, shell, TARDOXALTMto, Tel, theBank, theCanada, thecompany, theCooperative, theInsurance, theInvestment, theTrust, transform, unaffected, ZYPITAMAGTM

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

MCUJF similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 13.1 – CERTIFICATION OF CEO AND CFO PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Medicure Inc. (the “Company”), does hereby certify with respect to the Annual Report of the Company on Form 20-F for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Form 20-F”), that, to the best of his knowledge:

(1) the Form 20-F fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: April 20, 2021						/s/ Albert D. Friesen
						Albert D. Friesen Ph D., Chief Executive Officer
						(Principal Executive Officer)

Date: April 20, 2021						/s/ James F. Kinley
						James F. Kinley CA, Chief Financial Officer
						(Principal Financial Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.